A Study to Assess Adverse Events and Change in Disease Activity of JUVÉDERM® VOLITE™ XC Injectable Gel for Change in Neck Appearance in Adult Participants

PHASE3CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

September 12, 2024

Study Completion Date

September 12, 2024

Conditions
Neck Lines
Interventions
DEVICE

VOLITE XC

Intradermal Injection

DEVICE

VOLITE XC

Subdermal Injection

Trial Locations (15)

33134

Hevia Cosmetic Dermatology /ID# 239118, Coral Gables

70115

Delricht Research /ID# 242001, New Orleans

77401

Bellaire Dermatology Associates /ID# 239133, Bellaire

92663

Steve Yoelin MD Medical Associate Inc /ID# 239072, Newport Beach

95816-5520

Laser & Skin surgery Medical group, Inc /ID# 241999, Sacramento

92121-2119

Cosmetic Laser Dermatology /ID# 239121, San Diego

92075-2228

Art of Skin MD /ID# 239071, Solana Beach

20037-1445

Center for Dermatology and Dermatologic Surgery /ID# 239137, Washington D.C.

33146-1837

Skin Research Institute LLC /ID# 239109, Coral Gables

33401-2712

Research Institute of the Southeast, LLC /ID# 239070, West Palm Beach

20852-3093

Rkmd, Llc /Id# 239075, North Bethesda

07042

image Dermatology, P.C. /ID# 239136, Montclair

10022-3607

Skin And Aesthetics Surgery Of Manhattan /ID# 243607, New York

11795-4916

Mariwalla Dermatology /ID# 239102, West Islip

27517-9901

Aesthetic Solutions /ID# 239074, Chapel Hill

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY